Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $10.96 billion. The enterprise value is $10.06 billion.
| Market Cap | 10.96B |
| Enterprise Value | 10.06B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025, after market close.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 279.88 million shares outstanding. The number of shares has decreased by -7.88% in one year.
| Current Share Class | 279.88M |
| Shares Outstanding | 279.88M |
| Shares Change (YoY) | -7.88% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 77.31% |
| Float | 235.89M |
Valuation Ratios
The trailing PE ratio is 22.25 and the forward PE ratio is 19.25. Exelixis's PEG ratio is 1.17.
| PE Ratio | 22.25 |
| Forward PE | 19.25 |
| PS Ratio | 5.24 |
| Forward PS | 4.81 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 5.03 |
| P/FCF Ratio | 16.32 |
| P/OCF Ratio | 15.66 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.00, with an EV/FCF ratio of 14.99.
| EV / Earnings | 19.31 |
| EV / Sales | 4.64 |
| EV / EBITDA | 14.00 |
| EV / EBIT | 14.59 |
| EV / FCF | 14.99 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.63 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.32 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.13% and return on invested capital (ROIC) is 17.46%.
| Return on Equity (ROE) | 23.13% |
| Return on Assets (ROA) | 14.64% |
| Return on Invested Capital (ROIC) | 17.46% |
| Return on Capital Employed (ROCE) | 27.12% |
| Revenue Per Employee | $1.89M |
| Profits Per Employee | $454,461 |
| Employee Count | 1,147 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 3.84 |
Taxes
In the past 12 months, Exelixis has paid $160.37 million in taxes.
| Income Tax | 160.37M |
| Effective Tax Rate | 23.53% |
Stock Price Statistics
The stock price has increased by +76.29% in the last 52 weeks. The beta is 0.57, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +76.29% |
| 50-Day Moving Average | 35.03 |
| 200-Day Moving Average | 29.17 |
| Relative Strength Index (RSI) | 70.06 |
| Average Volume (20 Days) | 2,883,370 |
Short Selling Information
The latest short interest is 16.15 million, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 16.15M |
| Short Previous Month | 13.09M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 6.85% |
| Short Ratio (days to cover) | 5.82 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.17 billion and earned $521.27 million in profits. Earnings per share was $1.76.
| Revenue | 2.17B |
| Gross Profit | 2.09B |
| Operating Income | 689.95M |
| Pretax Income | 450.97M |
| Net Income | 521.27M |
| EBITDA | 718.75M |
| EBIT | 689.95M |
| Earnings Per Share (EPS) | $1.76 |
Balance Sheet
The company has $1.11 billion in cash and $215.83 million in debt, giving a net cash position of $895.44 million or $3.20 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 215.83M |
| Net Cash | 895.44M |
| Net Cash Per Share | $3.20 |
| Equity (Book Value) | 2.24B |
| Book Value Per Share | 7.97 |
| Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was $699.97 million and capital expenditures -$28.44 million, giving a free cash flow of $671.54 million.
| Operating Cash Flow | 699.97M |
| Capital Expenditures | -28.44M |
| Free Cash Flow | 671.54M |
| FCF Per Share | $2.40 |
Margins
Gross margin is 96.49%, with operating and profit margins of 31.81% and 24.04%.
| Gross Margin | 96.49% |
| Operating Margin | 31.81% |
| Pretax Margin | 31.43% |
| Profit Margin | 24.04% |
| EBITDA Margin | 33.14% |
| EBIT Margin | 31.81% |
| FCF Margin | 30.96% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.88% |
| Shareholder Yield | 7.88% |
| Earnings Yield | 4.76% |
| FCF Yield | 6.13% |
Analyst Forecast
The average price target for Exelixis is $37.24, which is -4.89% lower than the current price. The consensus rating is "Buy".
| Price Target | $37.24 |
| Price Target Difference | -4.89% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 10.31% |
| EPS Growth Forecast (5Y) | 27.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 8.25 and a Piotroski F-Score of 7.
| Altman Z-Score | 8.25 |
| Piotroski F-Score | 7 |